Determination of gefitinib in plasma by liquid chromatography with a C 12 column and electrospray tandem mass spectrometry detection

Journal of Liquid Chromatography and Related Technologies

Volumn 27, Issue 17, 2004, Pages 2743-2758

  Bai, Feng ^a   Iacono, Lisa C ^a   Johnston, Brad ^a   Stewart, Clinton F ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Electrospray tandem mass spectrometry; Gefitinib; Liquid chromatography; Plasma

Indexed keywords

ACETONITRILE; COLUMN CHROMATOGRAPHY; EXTRACTION; MASS SPECTROMETERS; MASS SPECTROMETRY; SEPARATION;

ELECTROSPRAY; GEFITINIB; HUMAN PLASMA; LIQUID-LIQUID EXTRACTION;

LIQUID CHROMATOGRAPHY;

ACETONITRILE; BUTYL METHYL ETHER; DIMETHYL ETHER; FORMIC ACID; GEFITINIB; HEPARIN; UNCLASSIFIED DRUG;

ARTICLE; DRUG DETERMINATION; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; IONIZATION; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY ELECTROSPRAY TANDEM MASS SPECTROMETRY; LIQUID LIQUID EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 5144224887     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-200029312     Document Type: Article

References (18)

1. Ciardiello, F.; Caputo, R.; Bianco, R.; Damiano, V.; Pomatico, G.; De Placido, S. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin. Cancer Res. 2000, 6, 2053-2063.
2. Sirotnak, F.M.; Zakowski, M.F.; Miller, V.A.; Scher, H.I.; Kris, M.G. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. Clin. Cancer Res. 2000, 6, 4885-4892.
3. Houghton, P.J.; Cheshire, P.J.; Harwood, F.G. Evaluation of ZD1839 (Iressa) alone and in combination with irinotecan (CPT-11) against pediatric solid tumor xenografts. Proc 11th NCI-EORTC-AACR Symposium 6, 2000; 379.
4. Ranson, M.; Hammond, L.A.; Ferry, D.; Kris, M.; Tullo, A.; Murray, P.I. ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial. J. Clin. Oncol. 2002, 20, 2240-2250.
5. Swaisland, H.; Laight, A.; Stafford, L.; Jones, H.; Morris, C.; Dane, A.; Yates, R. Pharmacokinetics and tolerability of the orally active selective epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in healthy volunteers. Clin. Pharmacokinet. 2001, 40, 297-306.
6. Herbst, R.S.; Maddox, A.M.; Rothenberg, M.L.; Small, E.J.; Rubin, E.H.; Baselga, J. Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial. J. Clin. Oncol. 2002, 20, 3815-3825.
7. Jones, H.K.; Stafford, L.E.; Swaisland, H.C.; Payne, R. A sensitive assay for ZD1839 (Iressa) in human plasma by liquid-liquid extraction and high performance liquid chromatography with mass spectrometric detection: validation and use in Phase I clinical trials. J. Pharm. Biomed. Anal. 2002, 29, 221-228.
8. Ermer, J.; Vogel, M. Applications of hyphenated LC-MS techniques in pharmaceutical analysis. Biomed. Chromatogr. 2000, 14, 373-383.
9. Mercier, J.P.; Debrun, J.L.; Dreux, M.; Elfakir, C.; Hakim, B. Mass spectrometric study of randomly methylated beta-cyclodextrins using ionspray, atmospheric pressure chemical ionization and matrix-assisted laser desorption/ionization. Rapid Commun. Mass Spectrom. 2000, 14, 68-70.
10. Niessen, W.M.A.; Tinke, A.P. Liquid-chromatography mass-spectrometry - general-principles and instrumentation. J. Chromatogr. A 1995, 703, 37-57.
11. Bramer, S.L.; Tata, P.N.; Vengurlekar, S.S.; Brisson, J.H. Method for the quantitative analysis of cilostazol and its metabolites in human plasma using LC/MS/MS. J. Pharm. Biomed. Anal. 2001, 26, 637-650.
12. Careri, M.; Elviri, L.; Mangia, A. Validation of a liquid chromatography ionspray mass spectrometry method for the analysis of flavanones, flavones and flavonols. Rapid Commun. Mass Spectrom. 1999, 13, 2399-2405.
13. Griffiths, W.J.; Jonsson, A.P.; Liu, S.; Rai, D.K.; Wang, Y. Electrospray and tandem mass spectrometry in biochemistry. Biochem. J. 2001, 355, 545-561.
14. Loo, J.A. Studying noncovalent protein complexes by electrospray ionization mass spectrometry. Mass Spectrom. Rev. 1997, 16, 1-23.
15. Mulvana, D.; Jemal, M.; Pulver, S.C. Quantitative determination of pravastatin and its biotransformation products in human serum by turbo ion spray LC/MS/MS. J. Pharm. Biomed. Anal. 2000, 23, 851-866.
16. Wu, J.; Xie, W.; Pawliszyn, J. Automated in-tube solid phase micro-extraction coupled with HPLC-ES-MS for the determination of catechins and caffeine in tea. Analyst 2000, 125, 2216-2222.
17. Zhao, J.J.; Xie, I.; Rogers, J.D. Determination of L-753,037 in human plasma by liquid chromatography/turbo ionspray tandem mass spectrometry. J. Mass Spectrom. 1999, 34, 1018-1027.
18. Jemal, M.; Ouyang, Z.; Chen, B.C.; Teitz, D. Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 1999, 13, 1003-1015.